Bridgeway Capital Management, LLC Maia Biotechnology, Inc. Transaction History
Bridgeway Capital Management, LLC
- $4.76 Billion
- Q1 2024
A detailed history of Bridgeway Capital Management, LLC transactions in Maia Biotechnology, Inc. stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 45,700 shares of MAIA stock, worth $153,095. This represents 0.0% of its overall portfolio holdings.
Number of Shares
45,700
Previous 75,700
39.63%
Holding current value
$153,095
Previous $88,000
13.64%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding MAIA
# of Institutions
21Shares Held
661KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA282KShares$943,6340.0% of portfolio
-
Centric Wealth Management67.2KShares$225,1130.05% of portfolio
-
Geode Capital Management, LLC Boston, MA53.3KShares$178,4100.0% of portfolio
-
Virtu Financial LLC New York, NY32.5KShares$108,8310.01% of portfolio
-
Jane Street Group, LLC New York, NY25.1KShares$83,9670.0% of portfolio
About MAIA Biotechnology, Inc.
- Ticker MAIA
- Exchange
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,935,900
- Market Cap $36.6M
- Description
- MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. Its lead asset, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company wa...